San Jose, CA, United States of America

Richard Himmelsbach


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 1991-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Richard Himmelsbach

Introduction

Richard Himmelsbach is a notable inventor based in San Jose, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel peptides for treating various health conditions. With a total of 2 patents, Himmelsbach's work has the potential to impact the treatment of serious diseases.

Latest Patents

Himmelsbach's latest patents focus on diol-containing renin inhibitors. These inventions concern novel renin-inhibitory peptides that are useful for treating renin-associated hypertension, congestive heart failure, hyperaldosteronism, and diseases caused by retroviruses, including HTLV-I and -III. The patents include processes for preparing the peptides, compositions containing them, and methods of using them. Additionally, a diagnostic method is included, which utilizes these compounds to determine the presence of renin-associated hypertension or hyperaldosteronism.

Career Highlights

Richard Himmelsbach is associated with Warner-Lambert Company, where he has contributed to various innovative projects. His work in the pharmaceutical industry has been instrumental in advancing treatments for critical health issues.

Collaborations

Himmelsbach has collaborated with notable coworkers, including John C. Hodges and James S. Kaltenbronn. Their combined expertise has fostered a productive environment for innovation and development.

Conclusion

Richard Himmelsbach's contributions to the field of pharmaceuticals through his patents on renin inhibitors highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…